Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAC-55649 is a retinoic acid receptor β2 (RARβ2) agonist.1 It selectively induces RARβ2 activity over RARα, RARβ1, and RARγ activity in functional assays using NIH3T3 cells (EC50s = 126, 2,512, 1,995, and 6,310 nM, respectively).2 AC-55649 reduces the proliferation of MCF-7 breast cancer cells in a concentration-dependent manner and induces neurite outgrowth in retinoid-responsive NTERA-2 cells when used at a concentration of 10 µM. It reduces fasting blood glucose levels in mice fed a high-fat diet as a model of type 2 diabetes.3
WARNING This product is not for human or veterinary use.
1. Discovery of a potent, orally available, and isoform-
2. Identification of novel subtype selective RAR agonists. Biochem. Pharmacol. 71(1-2), 156-162 (2025).
3. Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis. Diabetes Obes. Metab. 18(2), 142-151 (2016).